Becoming Certified in Addiction Medicine through ABPM (1.5 CME)
(1.5 CME) In this conference recording from the 2018 Annual Conference, you will discover that in the spring of 2017, ABPM offered physicians who are certified by a Member Board of the American Board of Medical Specialties (ABMS) the opportunity to apply and become certified in the subspecialty of Addiction Medicine. Marie A. Krousel-Wood, MD, MPH, ABPM Board Chair and Michael Weaver, MD, FASAM, Addiction Medicine Subboard Chair, will review the requirements and various pathways, i.e., Practice Pathway and Fellowship, available for physicians to apply for eligibility to sit for the Addiction Medicine subspecialty exam. Information on the timeline for the 2018 application cycle, dates for the examination period, and fee schedule will also be made available. Ample time will be provided for questions from the attendees.
For more information visit the ABPM website at www.theabpm.org.
Christopher J. Ondrula
Christopher J. Ondrula, is the Executive Director of the American Board of Preventative Medicine (ABMS). Prior to joining ABMS in 2015, Mr. Ondrula served as the Chief Executive Officer and Director at Heartland Food Corporation, and the former Chief Operating Officer and General Counsel for Spence Group Services.
A graduate of Miami University in Oxford, Ohio, Mr. Ondrula received his Juris Doctorate from Valparaiso University School of Law. Initially practicing in Chicago area law firms where his practice
focused on the defense of medical malpractice claims and product liability litigation, he later joined the Arena Football League as its Assistant General Counsel.
Michael F. Weaver
Dr. Michael Weaver is Professor of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addiction at The University of Texas McGovern Medical School at Houston. He completed a Residency in Internal Medicine and a Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University. He is involved in patient care, medical education, and research. Dr. Weaver has multiple publications in the field of addiction medicine. He treats patients at the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston, which provides medication-assisted treatment. He is the Sub-Board Chair for Addiction Medicine for the American Board of Preventive Medicine. He is a member of the ASAM Publications Council and on the Editorial Board for the Journal of Addiction Medicine.
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPM Maintenance of Certification (MOC)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.
ABAM Transitional Maintenance of Certification (tMOC)
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.